Pancreatic Cancer Research

ResearcherUniversity of PennsylvaniaNo recent work listed

David Balli

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3007-4495; OpenAlex author ID A5062847058; NIH RePORTER profile ID 10718935. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
1
Labs led
0
Collaborators
16
Papers, trials and grants by year

2015: 1 grant · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

  1. MYC Levels Regulate Metastatic Heterogeneity in Pancreatic Adenocarcinoma. Co-author DOI 10.1158/2159-8290.cd-20-1826↗
  2. Immune Cytolytic Activity Stratifies Molecular Subsets of Human Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-16-2128↗

Grants 1

  1. Genomic Landscape of Pancreatic Cancer Metastasis F32CA192761↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ben Z. Stanger · 2 shared papers, 2017–2022 · strength 0.20
  2. Robert J. Norgard · 1 shared paper, 2022 · strength 0.10
  3. John Christopher McAuliffe · 1 shared paper, 2022 · strength 0.10
  4. Pichai Raman · 1 shared paper, 2022 · strength 0.10
  5. Jinyang Li · 1 shared paper, 2022 · strength 0.10
  6. Ravikanth Maddipati · 1 shared paper, 2022 · strength 0.10
  7. Scott W. Lowe · 1 shared paper, 2022 · strength 0.10
  8. Taku Higashihara · 1 shared paper, 2022 · strength 0.10
  9. Timour Baslan · 1 shared paper, 2022 · strength 0.10
  10. Erica L. Carpenter · 1 shared paper, 2022 · strength 0.10
  11. Christine A. Iacobuzio–Donahue · 1 shared paper, 2022 · strength 0.10
  12. Jason Robert Pitarresi · 1 shared paper, 2022 · strength 0.10
  13. Faiyaz Notta · 1 shared paper, 2022 · strength 0.10
  14. Rolf A. Brekken · 1 shared paper, 2022 · strength 0.10
  15. Andrew J. Rech · 1 shared paper, 2017 · strength 0.10
  16. Robert H. Vonderheide · 1 shared paper, 2017 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.